Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p12
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 12/30)
Character Range: 35237–38059

"Purposes": P16238 P16249
[67] Schedule 1, Part 1, entry for Imatinib in the form Tablet 100 mg (as mesilate) [Brand: IMATINIB RBX; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[68] Schedule 1, Part 1, entry for Imatinib in the form Tablet 100 mg (as mesilate) [Brand: Imatinib Sandoz; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[69] Schedule 1, Part 1, entry for Imatinib in the form Tablet 100 mg (as mesilate) [Brand: Imatinib-Teva; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[70] Schedule 1, Part 1, entry for Imatinib in the form Tablet 400 mg (as mesilate) [Brand: Gilmat; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[71] Schedule 1, Part 1, entry for Imatinib in the form Tablet 400 mg (as mesilate) [Brand: Glivec; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[72] Schedule 1, Part 1, entry for Imatinib in the form Tablet 400 mg (as mesilate) [Brand: Imanib; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[73] Schedule 1, Part 1, entry for Imatinib in the form Tablet 400 mg (as mesilate) [Brand: IMATINIB RBX; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column